{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:59:45Z","timestamp":1773370785226,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jid.2024.02.038","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T05:45:19Z","timestamp":1714369519000},"page":"2671-2681.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Intravenous Ig Ameliorates Disease in a Murine Model of Anti\u2013Laminin 332 Mucous Membrane Pemphigoid"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3612-7532","authenticated-orcid":false,"given":"Sripriya","family":"Murthy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-3015","authenticated-orcid":false,"given":"Sabrina","family":"Patzelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0692-2105","authenticated-orcid":false,"given":"Axel","family":"K\u00fcnstner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-4521","authenticated-orcid":false,"given":"Hauke","family":"Busch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-8913","authenticated-orcid":false,"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6701-048X","authenticated-orcid":false,"given":"Christian D.","family":"Sadik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2024.02.038_bib1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archderm.139.8.1051","article-title":"Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases","volume":"139","author":"Ahmed","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2024.02.038_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/jdv.13397","article-title":"A\u00a0systematic review with pooled analysis of clinical presentation and immunodiagnostic testing in mucous membrane pemphigoid: association of anti-laminin-332 IgG with oropharyngeal involvement and the usefulness of ELISA","volume":"30","author":"Amber","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.02.038_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","article-title":"Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management","volume":"54","author":"Amber","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jid.2024.02.038_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/1346-8138.12502","article-title":"A\u00a0case of anti-BP180 type mucous membrane pemphigoid treated with intravenous immunoglobulin","volume":"41","author":"Aoki","year":"2014","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jid.2024.02.038_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.775412","article-title":"Subunit-specific reactivity of autoantibodies against Laminin-332 reveals direct inflammatory mechanisms on keratinocytes","volume":"12","author":"Bao","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2024.02.038_bib6","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.0022-202X.2005.23646.x","article-title":"Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA","volume":"124","author":"Bekou","year":"2005","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.02.038_bib7","article-title":"Role of immune cells in the ocular manifestations of pemphigoid diseases","volume":"11","author":"Bose","year":"2019","journal-title":"Ther Adv Ophthalmol"},{"key":"10.1016\/j.jid.2024.02.038_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification [published correction appears in Nat Biotechnol 2016;34:888]","volume":"34","author":"Bray","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jid.2024.02.038_bib9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2024.02.038_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13023-018-0855-x","article-title":"Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid","volume":"13","author":"Chiorean","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2024.02.038_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.immuni.2010.07.018","article-title":"Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis","volume":"33","author":"Chou","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2024.02.038_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103036","article-title":"Mucous membrane pemphigoid","volume":"21","author":"Du","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2024.02.038_bib13","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100145R","article-title":"Neutrophil extracellular traps contribute to immune dysregulation in bullous pemphigoid via inducing B-cell differentiation and antibody production","volume":"35","author":"Fang","year":"2021","journal-title":"FASEB J"},{"key":"10.1016\/j.jid.2024.02.038_bib14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3389\/fimmu.2019.00701","article-title":"NET formation in bullous pemphigoid patients with relapse is modulated by IL-17 and IL-23 interplay","volume":"10","author":"Giusti","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2024.02.038_bib15","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.jid.2017.03.037","article-title":"Experimental laminin 332 mucous membrane pemphigoid critically involves C5aR1 and reflects clinical and immunopathological characteristics of the human disease","volume":"137","author":"Heppe","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.02.038_bib16","first-page":"1530","article-title":"S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid","volume":"20","author":"Hofmann","year":"2022","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.jid.2024.02.038_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrd2909","article-title":"Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond","volume":"11","author":"Hogarth","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jid.2024.02.038_bib18","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.3389\/fimmu.2020.01858","article-title":"The G Protein-Coupled Receptor (GPR) 15 Counteracts Antibody-Mediated Skin Inflammation","volume":"11","author":"Jegodzinski","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2024.02.038_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fimmu.2019.00034","article-title":"The diagnosis and blistering mechanisms of mucous membrane pemphigoid","volume":"10","author":"Kamaguchi","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2024.02.038_bib20","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/bph.14986","article-title":"Treatment with anti-neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in mice","volume":"177","author":"Kasprick","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jid.2024.02.038_bib21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2133.1998.02502.x","article-title":"Antiepiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (alpha3beta3gamma2)","volume":"139","author":"Lazarova","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.02.038_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clim.2003.11.002","article-title":"A\u00a0nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies","volume":"111","author":"Letko","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jid.2024.02.038_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bjd.20099","article-title":"Clinical and immunological findings in 55 patients with anti-laminin 332-type mucous membrane pemphigoid","volume":"185","author":"Li","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2024.02.038_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1471-2105-10-161","article-title":"GAGE: generally applicable gene set enrichment for pathway analysis","volume":"10","author":"Luo","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jid.2024.02.038_bib25","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.jid.2021.04.009","article-title":"Dapsone suppresses disease in preclinical murine models of pemphigoid diseases","volume":"141","author":"Murthy","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.02.038_bib26","article-title":"Increased fibrosis in a mouse model of anti-laminin 332 mucous membrane pemphigoid remains unaltered by inhibition of aldehyde dehydrogenase","volume":"12","author":"Patzelt","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2024.02.038_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nmeth.4324","article-title":"Differential analysis of RNA-seq incorporating quantification uncertainty","volume":"14","author":"Pimentel","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.jid.2024.02.038_bib28","doi-asserted-by":"crossref","first-page":"E3177","DOI":"10.1073\/pnas.1213797109","article-title":"Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and Fc\u03b3R signaling","volume":"109","author":"Sadik","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jid.2024.02.038_bib29","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jid.2021.01.014","article-title":"Inhibition of glucose metabolism abrogates the effector phase of bullous pemphigoid-like epidermolysis bullosa acquisita","volume":"141","author":"Schilf","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.02.038_bib30","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/jdv.17395","article-title":"European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II","volume":"35","author":"Schmidt","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2024.02.038_bib31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2024.02.038_bib32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: how does IgG modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2024.02.038_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102528","article-title":"12\/15-lipoxygenase choreographs the resolution of IgG-mediated skin inflammation","volume":"115","author":"Sezin","year":"2020","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2024.02.038_bib34","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jid.2016.12.021","article-title":"The leukotriene B4 and its receptor BLT1 act as critical drivers of neutrophil recruitment in murine bullous pemphigoid-like epidermolysis bullosa acquisita","volume":"137","author":"Sezin","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2024.02.038_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.128239","article-title":"Dual inhibition of complement factor 5 and leukotriene B4 synergistically suppresses murine pemphigoid disease","volume":"4","author":"Sezin","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2024.02.038_bib36","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/ICO.0000000000001024","article-title":"Combined use of rituximab and intravenous immunoglobulin for severe autoimmune cicatricial conjunctivitis-an interventional case series","volume":"35","author":"Steger","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.jid.2024.02.038_bib37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.oooo.2015.01.024","article-title":"World Workshop on Oral Medicine VI: a systematic review of the treatment of mucous membrane pemphigoid","volume":"120","author":"Taylor","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2400304X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2400304X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T13:58:00Z","timestamp":1732802280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X2400304X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0022202X2400304X"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2024.02.038","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Ig Ameliorates Disease in a Murine Model of Anti\u2013Laminin 332 Mucous Membrane Pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2024.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}